<DOC>
	<DOCNO>NCT00391755</DOCNO>
	<brief_summary>To study effect Rozerem , high affinity MT1 MT2 , low affinity 5-HT2B receptor agonist use insomnia , migraine prophylactic agent .</brief_summary>
	<brief_title>A Double-Blind Placebo-Controlled Trial Rozerem Migraine Headaches</brief_title>
	<detailed_description>In recent , large study migraineurs , half report difficulty sleep initiation maintenance . Those short average sleep time report severe headache . Poor sleep associate increased frequency severity migraine . The improvement migraine frequency improve sleep hygiene document . PET image show increased regional cerebral blood flow neural structure involve sleep wake cycle migraine headache . Polysomnography show specific headache type occur specific sleep stage . Melatonin effective primarily headache due delay sleep phase syndrome . Recent study support efficacy melatonin treat migraine . The purpose study examine efficacy Rozerem prophylactic migraine medication . If effective , benefit drug prophylactic agent migraine include tolerability drug possible secondary benefit improvement sleep . Hypothesis : Rozerem decrease migraine frequency due improvement sleep possibly due share neurophysiology sleep migraine affect melatonin .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Age 1865 38 Migraine headaches/month Able understand comply study Currently migraine prophylaxis Currently sleep medication &gt; 4days/month Currently Fluvoxamine Untreated psychiatric sleep disorder MRI abnormality attributable migraine headache Abnormalities neurological exam know neurological disorder unassociated migraine sleep Known disorder prolactin Bipolar disorder Hepatic disease Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Migraine Headache</keyword>
</DOC>